Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory action/ inspection

Glenmark Pharmaceuticals has disclosed a GST adjudication order passed by the Joint Commissioner of Central GST & Central Excise, Mumbai East Commissionerate. The authority treated the company's sale of brand in FY 2020-21 as 'mixed supply' and demanded higher GST. The order demands Rs. 16.05 crore in CGST/SGST, similar amount as penalty, plus applicable interest. The order was passed on March 26, 2026 and received on March 31, 2026. Glenmark has stated it does not accept this demand and will file an appeal before the appropriate authority. The company claims there is no material impact on its financials or operations.